Baroness Brinton
Main Page: Baroness Brinton (Liberal Democrat - Life peer)
The Lord Speaker (Lord McFall of Alcluith)
My Lords, we have a virtual contribution from the noble Baroness, Lady Brinton.
Baroness Brinton (LD) [V]
My Lords, despite the Minister’s comments at the beginning of this Question, Nature published a report on 18 March saying that while vaccines protect against the omicron subvariant, their effect really does not last long. Will the Government place an order for the recently approved Evusheld as a pre-exposure prophylaxis drug, which Ministers have promised the very vulnerable since July last year? What steps are the Government taking to protect the severely immunocompromised in the longer term, including in their decision on who will be eligible for free lateral flow tests?
Baroness Bloomfield of Hinton Waldrist (Con)
I will do my best to answer the noble Baroness’s question, but it stretches into the health brief somewhat. On protection for the very vulnerable, on Monday we announced the rollout of the programme for the second booster for the vulnerable and the over-75s. It is not possible to predict what the long-term vaccine programme will look like, but undoubtedly there will be another vaccine in the autumn. We already have contracts in place for vaccines that we believe will be effective against any future variants and those trials have already started. Given the way the UK is approving these vaccines, with a rolling programme of research going to the regulatory authority, they can be approved very quickly and could even be introduced by September or October this year.